Unique ID issued by UMIN | UMIN000058702 |
---|---|
Receipt number | R000067117 |
Scientific Title | Effects of antidiabetic drugs on endogenous insulin secretion in non-insulin-dependent type 1 diabetes mellitus |
Date of disclosure of the study information | 2025/08/06 |
Last modified on | 2025/08/05 17:48:07 |
Effects of antidiabetic drugs on endogenous insulin secretion in non-insulin-dependent type 1 diabetes mellitus
Effects of antidiabetic drugs on endogenous insulin secretion in non-insulin-dependent type 1 diabetes mellitus
Effects of antidiabetic drugs on endogenous insulin secretion in non-insulin-dependent type 1 diabetes mellitus
Effects of antidiabetic drugs on endogenous insulin secretion in non-insulin-dependent type 1 diabetes mellitus
Japan |
diabetes
Endocrinology and Metabolism |
Others
NO
This study will identify a population of people who were initially diagnosed with type 2 diabetes and later re-diagnosed with type 1 diabetes, a group presumed to include individuals with features of slowly progressive type 1 diabetes (SPIDDM). The impact of diabetes medications on the trajectory of endogenous insulin secretion will then be examined in this cohort using real world data.
Efficacy
Confirmatory
Phase IV
The number of days from when the disease "type 2 diabetes" was diagnosed to when the disease "type 1 diabetes" was diagnosed (evaluated by whether or not SGLT2 inhibitors were introduced during that period)
The number of days from when the disease "type 2 diabetes" was diagnosed to when the disease "type 1 diabetes" was diagnosed (evaluated by whether or not SU, DPP-4i, and GLP-1RA were introduced during that period)
Others,meta-analysis etc
20 | years-old | <= |
Not applicable |
Male and Female
People who were initially diagnosed with type 2 diabetes (ICD-10 code: E12) and treated with antidiabetic drugs, and then diagnosed with type 1 diabetes (ICD-10 code: E10) between 90 days and less than 10 years after their type 2 diabetes diagnosis and in whom treatment with insulin preparations was initiated
1.People who developed diabetic ketoacidosis (E101 and E141) or were hospitalized within one month before or after the diagnosis of type 1 diabetes
2.The prescription of both long-acting and rapid-acting or ultra-rapid-acting insulin preparations prior to the diagnosis of type 1 diabetes had already been used.
3.The initiation of SGLT2i treatment followed the diagnosis of type 1 diabetes.
5000
1st name | Tomohisa |
Middle name | |
Last name | Seki |
The University of Tokyo Hospital
Department of Healthcare Information Management
113-8655
7-3-1, hongo, bunkyo-ku, Tokyo
03-3815-5411
seki@m.u-tokyo.ac.jp
1st name | KYUYONG |
Middle name | |
Last name | CHO |
Hokkaido University Hospital
Institute of Health Science Innovation for Medical Care
060-8648
N14W5, kita-ku, Sapporo, Hokkaido
011-706-1161
kyuyong-cho@pop.med.hokudai.ac.jp
The University of Tokyo
None
Other
IRB-A, The University of Tokyo, Graduate School of Medicine / Faculty of Medicine Institutional Review Board
7-3-1, hongo, bunkyo-ku, Tokyo
03-3815-5411
kyuyong-cho@pop.med.hokudai.ac.jp
YES
2025112NI
IRB-A, The University of Tokyo, Graduate School of Medicine / Faculty of Medicine Institutional Review Board
Hokkaido
東京大学医学部附属病院、北海道大学病院
2025 | Year | 08 | Month | 06 | Day |
Unpublished
Enrolling by invitation
2025 | Year | 05 | Month | 20 | Day |
2025 | Year | 07 | Month | 28 | Day |
2025 | Year | 07 | Month | 28 | Day |
2027 | Year | 03 | Month | 31 | Day |
None
2025 | Year | 08 | Month | 05 | Day |
2025 | Year | 08 | Month | 05 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000067117